TCR2 THERAPEUTICS INC. Quarterly Current Ratio in % from Q3 2019 to Q1 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Tcr2 Therapeutics Inc. quarterly Current Ratio history and growth rate from Q3 2019 to Q1 2023.
  • Tcr2 Therapeutics Inc. Current Ratio for the quarter ending March 31, 2023 was 384 %, a 73% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 384 -1.04K -73% Mar 31, 2023
Q4 2022 485 -1.57K -76.5% Dec 31, 2022
Q3 2022 740 -1.63K -68.8% Sep 30, 2022
Q2 2022 997 -1.75K -63.7% Jun 30, 2022
Q1 2022 1.42K -1.46K -50.6% Mar 31, 2022
Q4 2021 2.06K -534 -20.6% Dec 31, 2021
Q3 2021 2.37K -79.8 -3.25% Sep 30, 2021
Q2 2021 2.75K +609 +28.5% Jun 30, 2021
Q1 2021 2.88K +655 +29.4% Mar 31, 2021
Q4 2020 2.59K +190 +7.91% Dec 31, 2020
Q3 2020 2.45K +5.68 +0.23% Sep 30, 2020
Q2 2020 2.14K Jun 30, 2020
Q1 2020 2.22K Mar 31, 2020
Q4 2019 2.4K Dec 31, 2019
Q3 2019 2.45K Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.